4.7 Review

Bio-inspired nanomaterials as novel options for the treatment of cardiovascular disease

期刊

DRUG DISCOVERY TODAY
卷 26, 期 5, 页码 1200-1211

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2021.01.035

关键词

-

资金

  1. National Institute of Health [R01HL133153, R01HL122238, R01HL144550, R01HL102368]
  2. Department of Defense [OR170402]
  3. Department of Veterans Affairs [BX002327]

向作者/读者索取更多资源

Cardiovascular disease has long been a leading cause of death in developed countries, with mortality rates decreasing due to novel therapeutic options. However, there is a need for alternate therapeutic strategies, with the potential of nanomaterials being a promising avenue for research and development in this field.
Cardiovascular disease (CVD) and its sequelae have long been the leading causes of death and disability in the developed world. Although mortality associated with CVD has been decreasing, due in large part to novel therapeutic options, the rate of decrease has flattened. Thus, there is a great need to investigate alternate therapeutic strategies that can increase efficacy while decreasing adverse effects. Nanomaterials have been widely investigated and have emerged as promising tools for both therapeutic and diagnostic purposes in oncology; however, the potential of nanomaterials has not been extensively explored for cardiovascular medicine. In this review, we focus on recent developments in the field of nanomedicines targeted for CVDs, with a special emphasis on cell membrane-coated nanoparticles (NPs) and their applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications

Yan Shan Loo, Rajendran JC. Bose, Jason R. McCarthy, Intan Diana Mat Azmi, Thiagarajan Madheswaran

Summary: Smart nanocarriers derived from bacteria and viruses exhibit versatile biomimetic properties, making them suitable for use in biosensors, biomedical scaffolds, immobilization, diagnostics, and targeted or personalized treatments. Biomimetic technology plays a crucial role in pharmaceuticals, allowing for the safe integration of naturally occurring bacteria and virus particles.

DRUG DISCOVERY TODAY (2021)

Article Chemistry, Multidisciplinary

In Vivo Platelet Detection Using a Glycoprotein IIb/IIIa-Targeted Near-Infrared Fluorescence Imaging Probe

Khanh Ha, Xiaoxin Zheng, Chase W. Kessinger, Adam Mauskapf, Wenzhu Li, Yoichiro Kawamura, Makoto Orii, Scott A. Hilderbrand, Farouc A. Jaffer, Jason R. McCarthy

Summary: The study developed a near-infrared fluorescence probe based on tirofiban, which can rapidly and accurately visualize activated platelets in vivo, offering a potential new application for clinical diagnosis.

ACS SENSORS (2021)

Article Nanoscience & Nanotechnology

Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery

Rajendran J. C. Bose, Nagendran Tharmalingam, Yonghyun Choi, Thiagarajan Madheswaran, Ramasamy Paulmurugan, Jason R. McCarthy, Soo-Hong Lee, Hansoo Park

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Review Pharmacology & Pharmacy

Illuminating the druggable genome: Pathways to progress

Karlie R. Sharma, Christine M. Colvis, Griffih P. Rodgers, Douglas M. Sheeley

Summary: There are many genes within the druggable genome that have not been studied, and the US National Institutes of Health's program provides resources to explore these genes, with the potential for rapid impact on human health.

DRUG DISCOVERY TODAY (2024)

Review Pharmacology & Pharmacy

Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment

Mohammad Sameer Khan, B. H. Jaswanth Gowda, Waleed H. Almalki, Tanuja Singh, Amirhossein Sahebkar, Prashant Kesharwani

Summary: Mitochondria-specific functional liposomes hold great potential for cancer therapy. This review discusses the association between mitochondria and tumor formation, as well as the advantages of liposomes in delivering drugs to mitochondria.

DRUG DISCOVERY TODAY (2024)

Review Pharmacology & Pharmacy

Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities

Choong Yong Ung, Cristina Correia, Hu Li, Christopher M. Adams, Jennifer J. Westendorf, Shizhen Zhu

Summary: With increasing human life expectancy, the global medical burden of chronic diseases is growing. Chronic diseases often involve malfunctioning of multiple organs, and understanding the interorgan crosstalk is crucial to understanding the etiology of chronic diseases. Researchers have proposed the locked-state model (LoSM) and cutting-edge systems biology and artificial intelligence strategies to decipher chronic multiorgan locked states. The findings have important clinical implications for improving treatments for chronic diseases.

DRUG DISCOVERY TODAY (2024)